BỘ KHOA HỌC VÀ CÔNG NGHỆ
HỆ THỐNG THÔNG TIN KHOA HỌC VÀ CÔNG NGHỆ

Lọc theo danh mục
  • Năm xuất bản
    Xem thêm
  • Lĩnh vực
liên kết website
Lượt truy cập
 Lượt truy cập :  25,137,704
  • Công bố khoa học và công nghệ Việt Nam

Khoa học chính trị

Hoàng Huệ Anh, Hồ Thị Ánh Phương, TS Hoàng Huệ Anh(1)

Cạnh tranh vắc-xin Trung Quốc – Hoa Kỳ và những tác động

U.S.-China competition in vaccine diplomacy and its impacts

Tạp chí khoa học và công nghệ - Trường Đại Duy Tân

2022

53

104-113

1859-4905

Vắc xin, Covid-19, Chiến lược ngoại giao, Cạnh tranh, Tác động

Vaccine diplomacy, Competition, Impact, China, United States

Vắc-xin COVID-19 mang thuộc tính của một loại hàng hóa công toàn cầu. Bài viết thông qua phân tích chiến lược ngoại giao vắc-xin của Trung Quốc và Hoa Kỳ, nhận diện cuộc chạy đua giữa hai quốc gia trong lĩnh vực vắc-xin, trong bối cảnh đại dịch COVID-19 đã làm gia tăng căng thẳng giữa hai nước. Hai cường quốc vắc-xin thiếu vắng sự đồng thuận và phối hợp để giải quyết vấn đề tiêm chủng toàn cầu, cũng như đối phó với đại dịch Covid-19. Kết quả là thế giới đang đứng trước nguy cơ rơi vào một cuộc khủng hoảng của nền quản trị, khi mà không nước lớn nào có đủ năng lực đảm nhiệm vai trò cung cấp hàng hóa công toàn cầu.

The COVID-19 vaccine has c-haracteristics of a global public good. By analysing vaccine diplomacy strategies of China
and the United States, the article deciphers the vaccine race between the two countries as the COVID-19 pandemic has
reactivated and increased tension in Sino-American relations. The lack of consensus and coordination between the two
vaccine powers has hindered global efforts in tackling the vaccination problem and in dealing with the pandemic. As a
result, the world is on the brink of falling into a governance crisis because no major powers have enough capability to
provide global public goods.

TTKHCNQG, CVv 416

Xem toàn văn
  • [1] Zakaria, F (2021), This is just the first in a series of cascading crises,The Washington Post. 3 April 2020, available at: www.washingtonpost.com/opinions/globalopinions/this-is-just-the-first-in-a- series-ofcascading-crises/2020/04/02/45e8cc52-7510-11ea87da-77a8136c1a6d_story.html
  • [2] John Kampfner (2021), Vaccine competition may now be the world’s best,Chatham House https://www.chathamhouse.org/2021/06/vaccinecompetition-may-now-be-worlds-best-bet#us-talksof-vaccine-donations
  • [3] Zheng, C (2020), China’s global governance challenge and domestic reforms: rethinking the ‘Kindleberger trap’ and its implications for the rise of China,The Diplomat. 23 March 2020, available at: https://thediplomat.com/2017/03/chinas-globalgovernance-challenge-and-dome stic-reforms/
  • [4] Victor Tay (2021), China and US Vaccines Diplomacy in South East Asia.,https://www.rhtlawasia.com/china-and-us-vaccinesdiplomacy-in-south-east-asia/
  • [5] (2021), Coronavirus live: China’s Sinopharm jab gets WHO approval; Turkey, Maldives and Nepal added to England ‘red list’. May 7.,https://www.theguardian.com/world/live/2021/may/ 07/coronavirus-live-news-who-warns-of-risk-ofsecond-wave-in-africa-india-cases-rise-by-worldrecord-414188?page=with:block6094b8418f084128b7c97d63&filterKeyEvents=false
  • [6] Leng, Alyssa, Rajah, Roland and Lemahieu, Herve (2022), Vaccine Diplomacy in Asia.,The Diplomat, March 1. https://thediplomat.com/2022/03/vaccinediplomacy-in-asia/
  • [7] Leng, Alyssa, Rajah, Roland and Lemahieu, Herve (2021), Vaccine Diplomacy in Asia.,The Diplomat, March 1. https://thediplomat.com/2022/03/vaccinediplomacy-in-asia/
  • [8] Lovelace, Berkeley Jr (2021), U.S. to share 60 million doses of AstraZeneca Covid vaccine with other countries.,CNBC, April 26. https://www.cnbc.com/2021/04/26/covid-vaccine us-to-share-60-million-astrazeneca-doses-withother-countries.html
  • [9] Evan Cooper and Mathew Burrows (2021), Reality Check #6: The consequences of an ‘America First’ vaccine policy.,https://www.atlanticcouncil.org/contentseries/reality-check/reality-check-6-theconsequences-of-an-america-first-vaccine-policy/
  • [10] Liu, A (2020), Sinopharm chief says COVID-19 vaccine will cost less than $145 for 2-dose regimen.,Fierce Pharma, August 18. https://www.fiercepharma.com/vaccines/chinasinopharm-chief-narrowsdown-covid-19-vaccineprice-to-within-145-for-2-dose-regimen
  • [11] Beaubien, J (2021), Price check: Nations pay wildly different prices for vaccine.,NPR News, February 19. https://www.npr.org/sections/goatsandsoda/2021/02/ 19/969529969/price-check-nationspay-wildlydifferent-prices-for-vaccines
  • [12] Karásková, I., and V. Blablová (2021), The logic of China’s vaccine diplomacy.,The Diplomat, March 24. https://thediplomat.com/2021/03/the-logic-ofchinas-vaccine-diplomacy/.
  • [13] Zhao, Suisheng (2022), Why China’s vaccine diplomacy is winning,East Asia Forum, April 29, 2021. https://www.eastasiaforum.org/2021/04/29/whychinas-vaccine-diplomacy-is-winning/
  • [14] (2021), Wang Yi: China to Strengthen Vaccine Cooperation with Developing Countries,June 6. https://www.mfa.gov.cn/ce/ceegy/eng/zgyw/t1881656.htm
  • [15] Leng, Alyssa, Rajah, Roland and Lemahieu, Herve (2022), Vaccine Diplomacy in Asia.,The Diplomat, March 1. https://thediplomat.com/2022/03/vaccinediplomacy-in-asia/
  • [16] Doherty, B., D. Hurst, and K. Lyons (2021), Coercion or altruism: Is China using its Covid vaccines to wield global power? The Guardian, March 27.,https://www.theguardian.com/australianews/2021/mar/28/coercion-or-altruism-is-chinausing-its-covid-vaccines-to-wield-global-power
  • [17] Wheaton, S (2020), Chinese vaccine would be ‘global public good,’ Xi says.,Arlington: Politico
  • [18] (2021), Foreign Ministry Spokesperson Zhao Lijian's Regular Press Conference, 15 January, 2021.,https://www.fmprc.gov.cn/nanhai/eng/fyrbt_1/t1846 677.htm
  • [19] 喻小勇, 田 侃 (), 全球公共产品视角下新冠疫苗 供给分配的困境、成因与应对,南京社会科， 2021年9月
  • [20] Gavi (2020), Are vaccines a global public good?,https://www.gavi.org/vaccineswork/are-vaccinesglobal-public-good
  • [21] (2021), COVID-19 Vaccines Must Be Global Public Good, Secretary-General Says, Announcing ‘Only Together’ Campaign to Encourage Sharing of Technology,Doses. https://www.un.org/press/en/2021/sgsm20620.doc.htm
  • [22] Gavi (2020), Are vaccines a global public good?,https://www.gavi.org/vaccineswork/are-vaccinesglobal-public-good